Pharmaceutical Intermediate Nilotinib Raw Material Nilotinib Powder Anticancer Nilotinib

• Customization: Available
• Powder: Yes
• Customized: Customized
• Model NO.: Dsung-Nilotinib
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Product Name: Nilotinib
• Name: Nilotinib Powder
• Appearance: White Powder
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Anticancer
• Specific: COA
• Test Method: HPLC
• Shelf Life: 2 Years
• CAS No.: 641571-10-0
• Molecular Formula: C28h22f3n7o
• Einecs No.: 700-544-5
• Melting Point: 230-242 C
• Refractive Index: 1.65
• Density: 1.36
• Transport Package: Negotiable
• Specification: 99%
• Trademark: D-Sung
• Origin: Shaanxi
• Production Capacity: 10kg/Month

Product Description

Pharmaceutical Intermediate Nilotinib Raw Material Nilotinib Powder Anticancer Nilotinib

 

Product Description

Product Details

Product Name	Nilotinib
CAS NO.	641571-10-0
Purity	99%
Melting point	230-242 C
Appearance and shape	White powder

Nilotinib (Tasigna) is a new type of targeted cancer therapy, which belongs to the tyrosine kinase inhibitor, for the treatment of Gleevec (imatinib) resistant chronic myelogenous leukemia (CML) patients, curative effect.
Nilotinib is a molecular structure of imatinib imatinib improved and has better selectivity to BCR-ABL kinase activity, inhibition of tyrosine kinase compared with imatinib 30 times stronger inhibition on imatinib resistant mutant BCR-ABL kinase activity. It also inhibits the activity of KIT and PDGFR kinase.

Application & Function

A powerful and precise second-generation tyrosine kinase inhibitor, effective in treating patients with drug-resistant or intolerant chronic myelogenous leukemia.
Nilotinib is an antitumor drug, and it is mainly used clinically to treat chronic myelogenous leukemia that is resistant to Gleevec (imatinib).

Specification